Brief: Vicore Pharma Holding Q2 Operating Loss Widens To SEK 68.4 Mln
26/08/2021 07:24
Aug 26 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* INTERIM REPORT APRIL - JUNE 2021
* Q2 OPERATING LOSS WAS -68.4 MSEK (-27.5)
* Q2 LOSS FOR PERIOD AMOUNTED TO -70.4 MSEK (-24.2)
Source text for Eikon: ID:nWkr7MDRvC
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2